Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0HTC.L Stock Summary
Top 10 Correlated ETFs
0HTC.L
In the News
0HTC.L Financial details
Company Rating
Neutral
Market Cap
49.49M
Income
-118.51M
Revenue
20.97M
Book val./share
1.05
Cash/share
1.86
Dividend
-
Dividend %
-
Employees
55
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-0.32
Forward P/E
-0.75
PEG
-0.09
P/S
1.77
P/B
0.43
P/C
0.44
P/FCF
-0.38
Quick Ratio
3.58
Current Ratio
4.4
Debt / Equity
0.65
LT Debt / Equity
0.65
-
-
EPS (TTM)
-2.18
EPS next Y
-1.1
EPS next Q
-0.41
EPS this Y
37.74%
EPS next Y
-49.63%
EPS next 5Y
-86.93%
EPS last 5Y
-2.53%
Revenue last 5Y
1.07%
Revenue Q/Q
-38.27%
EPS Q/Q
13.46%
-
-
-
-
SMA20
11.54%
SMA50
42.62%
SMA100
-28.69%
Inst Own
-
Inst Trans
-
ROA
-101%
ROE
-95%
ROC
-1.3%
Gross Margin
-431%
Oper. Margin
-566%
Profit Margin
-549%
Payout
-
Shs Outstand
56.73M
Shs Float
48.18M
-
-
-
-
Target Price
-
52W Range
0.5-5.815
52W High
-
52W Low
-
RSI
49
Rel Volume
0.64
Avg Volume
18.63K
Volume
11.97K
Perf Week
-2.95%
Perf Month
47.32%
Perf Quarter
-43.1%
Perf Half Y
-52.59%
-
-
-
-
Beta
0.695
-
-
Volatility
0.05%, 0.13%
Prev Close
4.43%
Price
0.825
Change
-4.06%
0HTC.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.47 | 2.85 | 0.45 | 0.78 | 0.39 | |
Net income per share | -2.49 | 0.18 | -1.74 | -1.59 | -2.19 | |
Operating cash flow per share | -2.56 | -0.12 | -1.18 | -1.47 | -1.7 | |
Free cash flow per share | -2.56 | -0.12 | -1.19 | -1.47 | -1.74 | |
Cash per share | 3.63 | 3.82 | 3.29 | 2.72 | 1.87 | |
Book value per share | 4.38 | 5.25 | 4.49 | 2.96 | 1.05 | |
Tangible book value per share | 4.38 | 5.25 | 4.49 | 2.96 | 1.05 | |
Share holders equity per share | 4.38 | 5.25 | 4.49 | 2.96 | 1.05 | |
Interest debt per share | 0.02 | 0.03 | 0.03 | 0.04 | 0.7 | |
Market cap | 1.02B | 955M | 640.58M | 579.89M | 39.53M | |
Enterprise value | 1.01B | 928.59M | 630.8M | 517.66M | 30.51M | |
P/E ratio | -9.6 | 113.56 | -7.24 | -6.78 | -0.33 | |
Price to sales ratio | 51.37 | 7.07 | 27.82 | 13.85 | 1.89 | |
POCF ratio | -9.35 | -174.05 | -10.66 | -7.37 | -0.43 | |
PFCF ratio | -9.35 | -163.64 | -10.65 | -7.36 | -0.42 | |
P/B Ratio | 5.47 | 3.84 | 2.82 | 3.65 | 0.69 | |
PTB ratio | 5.47 | 3.84 | 2.82 | 3.65 | 0.69 | |
EV to sales | 50.66 | 6.87 | 27.39 | 12.36 | 1.46 | |
Enterprise value over EBITDA | -9.09 | 145.09 | -7.21 | -6.03 | -0.25 | |
EV to operating cash flow | -9.22 | -169.23 | -10.5 | -6.58 | -0.33 | |
EV to free cash flow | -9.22 | -159.11 | -10.49 | -6.57 | -0.32 | |
Earnings yield | -0.1 | 0.01 | -0.14 | -0.15 | -3 | |
Free cash flow yield | -0.11 | -0.01 | -0.09 | -0.14 | -2.39 | |
Debt to equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.65 | |
Debt to assets | 0 | 0.01 | 0.01 | 0.01 | 0.29 | |
Net debt to EBITDA | 0.13 | -4.13 | 0.11 | 0.72 | 0.07 | |
Current ratio | 3.86 | 10.55 | 9.84 | 7.2 | 4.54 | |
Interest coverage | 0 | 0 | 0 | 0 | -201.15 | |
Income quality | 1.03 | -0.65 | 0.68 | 0.92 | 0.78 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.88 | 0.16 | 1.26 | 0.71 | 0 | |
Research and developement to revenue | 5.72 | 0.8 | 3.59 | 2.19 | 5.17 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0.06 | 0 | 0 | 0.03 | |
Capex to revenue | 0 | 0 | 0 | 0 | -0.11 | |
Capex to depreciation | -0.02 | -0.34 | -0.03 | -0.03 | -9.17 | |
Stock based compensation to revenue | 0.63 | 0.11 | 0.9 | 0.42 | 0 | |
Graham number | 15.67 | 4.58 | 13.27 | 10.3 | 7.21 | |
ROIC | -0.58 | 0.02 | -0.39 | -0.54 | -1.21 | |
Return on tangible assets | -0.46 | 0.03 | -0.36 | -0.47 | -0.94 | |
Graham Net | 2.58 | 3.38 | 2.95 | 2.36 | 0.68 | |
Working capital | 122.76M | 176.58M | 155.67M | 145.45M | 90.57M | |
Tangible asset value | 186.71M | 249M | 227.52M | 158.78M | 57.09M | |
Net current asset value | 119.41M | 172.91M | 153.76M | 145.45M | 47.4M | |
Invested capital | 0.01 | 0.01 | 0.01 | 0.01 | 0.65 | |
Average receivables | 893.5K | 1.93M | 1.61M | 2.8M | 4.24M | |
Average payables | 6.74M | 7M | 5.26M | 7.61M | 10.59M | |
Average inventory | 0 | 0 | 1.29M | 2.48M | 2.6M | |
Days sales outstanding | 32.8 | 5.58 | 18.26 | 38.82 | 69.93 | |
Days payables outstanding | 29.35 | 16.68 | 1.32K | 466.52 | 657.2 | |
Days of inventory on hand | 0 | 0 | 606.92 | 115.76 | 160.06 | |
Receivables turnover | 11.13 | 65.45 | 19.99 | 9.4 | 5.22 | |
Payables turnover | 12.44 | 21.88 | 0.28 | 0.78 | 0.56 | |
Inventory turnover | 0 | 0 | 0.6 | 3.15 | 2.28 | |
ROE | -0.57 | 0.03 | -0.39 | -0.54 | -2.08 | |
Capex per share | 0 | -0.01 | 0 | 0 | -0.04 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.06 | 0.11 | 0.13 | 0.09 | 0.06 | |
Net income per share | -0.56 | -0.49 | -0.58 | -0.52 | -0.59 | |
Operating cash flow per share | -0.44 | -0.64 | -0.38 | -0.36 | -0.32 | |
Free cash flow per share | -0.44 | -0.64 | -0.38 | -0.37 | -0.36 | |
Cash per share | 2.71 | 2.13 | 1.76 | 1.46 | 1.86 | |
Book value per share | 2.95 | 2.54 | 2.02 | 1.58 | 1.05 | |
Tangible book value per share | 2.95 | 2.54 | 2.02 | 1.58 | 1.05 | |
Share holders equity per share | 2.95 | 2.54 | 2.02 | 1.58 | 1.05 | |
Interest debt per share | 0.04 | 0.03 | 0.02 | 0.01 | 0.69 | |
Market cap | 581.07M | 268.76M | 154.45M | 88.95M | 39.77M | |
Enterprise value | 518.84M | 222.42M | 96.77M | 32.98M | 30.75M | |
P/E ratio | -4.79 | -2.52 | -1.23 | -0.79 | -0.31 | |
Price to sales ratio | 178.19 | 43.59 | 22.28 | 18.28 | 13.24 | |
POCF ratio | -24.72 | -7.76 | -7.55 | -4.53 | -2.29 | |
PFCF ratio | -24.72 | -7.76 | -7.55 | -4.45 | -2.05 | |
P/B Ratio | 3.66 | 1.97 | 1.42 | 1.04 | 0.7 | |
PTB ratio | 3.66 | 1.97 | 1.42 | 1.04 | 0.7 | |
EV to sales | 159.1 | 36.08 | 13.96 | 6.78 | 10.24 | |
Enterprise value over EBITDA | -16.8 | -8.17 | -3.03 | -1.16 | -0.95 | |
EV to operating cash flow | -22.07 | -6.42 | -4.73 | -1.68 | -1.77 | |
EV to free cash flow | -22.07 | -6.42 | -4.73 | -1.65 | -1.58 | |
Earnings yield | -0.05 | -0.1 | -0.2 | -0.32 | -0.81 | |
Free cash flow yield | -0.04 | -0.13 | -0.13 | -0.22 | -0.49 | |
Debt to equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.65 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0 | 0.29 | |
Net debt to EBITDA | 2.02 | 1.7 | 1.81 | 1.97 | 0.28 | |
Current ratio | 7.2 | 8.55 | 4.9 | 4.4 | 4.54 | |
Interest coverage | 0 | 0 | 0 | 0 | -53.99 | |
Income quality | 0.77 | 1.3 | 0.65 | 0.7 | 0.54 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.93 | 1.1 | 1.07 | 1.36 | 0 | |
Research and developement to revenue | 7.97 | 3.94 | 4.37 | 5.22 | 9.44 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0.02 | 0.12 | |
Capex to revenue | 0 | 0 | 0 | -0.07 | -0.68 | |
Capex to depreciation | 0 | 0 | 0 | -0.62 | -25.02 | |
Stock based compensation to revenue | 0.89 | 0.54 | 0.5 | 0.69 | 0 | |
Graham number | 6.12 | 5.31 | 5.14 | 4.29 | 3.74 | |
ROIC | -0.19 | -0.2 | -0.29 | -0.31 | -0.33 | |
Return on tangible assets | -0.17 | -0.17 | -0.23 | -0.24 | -0.26 | |
Graham Net | 2.36 | 1.95 | 1.48 | 1.02 | 0.68 | |
Working capital | 145.45M | 125.98M | 99.28M | 77.72M | 90.57M | |
Tangible asset value | 158.78M | 136.6M | 108.93M | 85.64M | 57.09M | |
Net current asset value | 145.45M | 125.98M | 99.28M | 70.91M | 47.4M | |
Invested capital | 0.01 | 0.01 | 0.01 | 0.01 | 0.65 | |
Average receivables | 7.61M | 5.86M | 9.25M | 8.49M | 4.87M | |
Average payables | 12.41M | 7.01M | 8.27M | 10.05M | 9.78M | |
Average inventory | 2.11M | 2.95M | 3.47M | 3.34M | 3.04M | |
Days sales outstanding | 122.9 | 105.96 | 145.92 | 105.98 | 120.35 | |
Days payables outstanding | 394.5 | 150.36 | 738.15 | 444.04 | 1.51K | |
Days of inventory on hand | 97.89 | 119.47 | 208.25 | 181.78 | 367.96 | |
Receivables turnover | 0.73 | 0.85 | 0.62 | 0.85 | 0.75 | |
Payables turnover | 0.23 | 0.6 | 0.12 | 0.2 | 0.06 | |
Inventory turnover | 0.92 | 0.75 | 0.43 | 0.5 | 0.24 | |
ROE | -0.19 | -0.2 | -0.29 | -0.33 | -0.57 | |
Capex per share | 0 | 0 | 0 | -0.01 | -0.04 |
0HTC.L Frequently Asked Questions
What is Cara Therapeutics, Inc. stock symbol ?
Cara Therapeutics, Inc. is a US stock , located in Stamford of Ct and trading under the symbol 0HTC.L
What is Cara Therapeutics, Inc. stock quote today ?
Cara Therapeutics, Inc. stock price is $0.825 today.
Is Cara Therapeutics, Inc. stock public?
Yes, Cara Therapeutics, Inc. is a publicly traded company.